These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 520360)

  • 1. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma.
    Lindberg S; Ernest I; Fjälling M; Holmdahl C
    Nucl Med Commun; 1985 Jan; 6(1):31-6. PubMed ID: 3039430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
    Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
    Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
    Reschini E; Baldini M; Cantalamessa L
    Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
    García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
    Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
    Gross MD; Shapiro B; Freitas JE
    J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
    Sialer G; Marincek B; Mengden T; Vetter W
    Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
    Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
    Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I
    Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphy with 131I-19-iodocholesterol in adrenal disease.
    Jorgensen H; Norman N; Sundsfjord JA
    Acta Med Scand; 1975 May; 197(5):345-51. PubMed ID: 1146612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of adrenal venography and iodocholesterol scan in adrenal surgery.
    Herwig KR; Sonda LP
    J Urol; 1979 Jul; 122(1):7-8. PubMed ID: 458994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome.
    Bui F; Macri' C; Varotto L; Boscaro M; Mantero F
    Cardiology; 1985; 72 Suppl 1():76-83. PubMed ID: 2996768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scanning of the adrenals in Cushing's syndrome.
    Gogas JG; Skalkeas GD; Sechas MN; Skandalakis PN
    Am Surg; 1987 Aug; 53(8):472-5. PubMed ID: 3605868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.